710-1264

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-06-13

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-09-29 (study day 109.0); relationship: POSSIBLE

moderate assessed

Moderate CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-10-09 (study day 119.0); relationship: POSSIBLE

moderate assessed

Moderate CHILLS — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 121.0); relationship: POSSIBLE

moderate assessed

Moderate COLD SWEAT — outcome: RECOVERED/RESOLVED; onset 2013-09-29 (study day 109.0); relationship: POSSIBLE

moderate assessed

Moderate COLD SWEAT — outcome: RECOVERED/RESOLVED; onset 2013-10-09 (study day 119.0); relationship: POSSIBLE

moderate assessed

Moderate COLD SWEAT — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 121.0); relationship: POSSIBLE

mild assessed

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-07-03 (study day 21.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-21 (study day 70.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-21 (study day 70.0); relationship: POSSIBLE

Data queries

No data queries.